Hemostemix to Attend DFCon San Antonio and Closed its Private Placement

Stock Information for InMed Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About InMed Pharmaceuticals Inc.

Hemostemix Welcomes Shaune Harding, OStJ, RN as Director of Patient Care & Clinical Operations
Hemostemix Featured at Innovations in Wound Healing 2025, Key West, December 11-14
Hemostemix Starts its Roll-up of Cardiology Practices, Acquiring its First Two
Dr. William R. Shankle to Advance ACP-01 as a Treatment for Vascular Dementia
Hemostemix Closes CDN$280,594 Private Placement
Hemostemix to Showcase Breakthrough Wound Healing Therapy at Innovations in Wound Care Conference Florida
Hemostemix Presents ACP-01 Data at University of Florida Grand Rounds: Highlights Strong Safety, Functional Gains, and Florida Access Pathway
Hemostemix Closes Private Placement of $461,230

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.